Bryan Fellman

The University of Texas MD Anderson Cancer Center

Papers

Total Citations

H-Index

About

Bryan Fellman is a biostatistician and researcher whose work centers on urologic oncology, surgical outcomes, and predictive modeling in cancer care. His major contributions include elucidating the incidence and risk factors for intraoperative conversion from partial to radical nephrectomy—a critical decision point in kidney cancer surgery. In his highly cited 2018 study, he demonstrated that conversion occurs in a small but significant proportion of cases, with tumor complexity and surgeon experience as key predictors, providing actionable insights for preoperative planning and patient counseling. With over 31 citations, this work has informed clinical guidelines and surgical decision-making. Beyond this, Fellman’s research spans statistical methodology for clinical trials and outcomes research, often collaborating on studies that improve risk stratification and treatment personalization for renal cell carcinoma and other malignancies. His expertise in biostatistics has been instrumental in advancing evidence-based urologic surgery, making his work a valuable resource for clinicians and researchers seeking to reduce surgical complications and optimize patient outcomes.